Clinical Trials in San Antonio

Showing 2001-2020 of 12,572 trials

A Phase 3 Study of F14 for Management of Pain Following Total Knee Replacement

NCT05603832

This is a Phase 3, randomized, double blind, multicenter study to evaluate the analgesic efficacy and safety of a single intra-articular dose of F14 (625 mg sustained release celecoxib) administered concurrent with multimodal analgesia in patients undergoing total knee replacement surgery, compared to multimodal analgesia alone.

Post Operative Pain

Arthritis Innovation Corporation151 participantsStarted Nov 2022

Little Rock, Arkansas, United States • Tamarac, Florida, United States • Tulsa, Oklahoma, United States +4 more locations

Active Not RecruitingPhase 4< 1 mile

STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss

NCT06571383

The study is testing how well semaglutide can help adolescents with excess body weight to lose weight and to maintain weight loss. All participants in the study will receive semaglutide as a weekly injection. The study medicine is injected with a thin needle in the stomach, thighs or upper arms. All participants will get semaglutide treatment for a minimum of 3 years.

Obesity

Novo Nordisk A/S500 participantsStarted Sep 2024

Escondido, California, United States • Orlando, Florida, United States • Tallahassee, Florida, United States +90 more locations

A Phase 3 Study of F14 for Management of Pain Following Total Knee Replacement

STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss

Find Trials by Condition in San Antonio

SyncAV Post-Market Trial

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis

Multisite Virtual Reality Intervention for Speech Anxiety

The Johns Hopkins Heartburn Center Registry

A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies

Blue Light Cystoscopy With Cysview® Registry

A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS

M9466 in Combination With Topoisomerase 1 Inhibitors-based Regimens in Advanced Solid Tumors and Colorectal Cancer (DDRiver 511)

Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers

HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP

HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)

A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease

A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors

Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors

A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of Relutrigine

Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor

Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX